期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药物支架应用于冠状动脉介入治疗中的现状和前景 被引量：3

Current Situation and Perspective of Drug-Eluting Stents in Intracoronany Interventional Therapy
暂未订购
导出
摘要 目前越来越多的冠状动脉性心脏病患者接受了经皮冠状动脉介入治疗,药物支架也已成为介入治疗的焦点。通过对药物支架和裸支架的比较,指出了药物支架的特点和优势,以及药物支架发展至今其安全性的争议和研究进展,并预测了其未来的发展方向。随着药物支架的不断发展,介入心脏病学必将会迎来更多的革命。药物支架取代裸支架是一种必然的趋势,可降解支架的发展则是新的里程碑。 Currently, the number of patients with coronary artery disease undergoing percutanous coronary intervention is increasing. Drug-eluting stents have become the focus of this therapy. Through comparing and contrasting drug-eluting stents with metal bare stents, we will present the advantages, safety concerns, and future development of the drug-eluting stents.
作者 周亮 徐岩
机构地区 安徽医科大学第一附属医院心血管内科
出处 《心血管病学进展》 CAS 2009年第3期442-445,共4页 Advances in Cardiovascular Diseases
关键词 介入治疗 药物支架 冠状动脉性心脏病 可降解支架 intracoronary interventional therapy drug-eluting stents coronary artery disease biodegradable stent
分类号 R541.4 [医药卫生—心血管疾病] R815 [医药卫生—放射医学]
  • 相关文献

参考文献23

  • 1Berger PB,Holmes DR Jr,Ohman EM,et al.Restenosis,reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries.Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)[J].J Am Coll Cardiol,1996,27(1):1-7.
  • 2Saito S,Hosokawa FG,Kim K,et al.Primary stent implantation without coumadin in acute myocardial infarction[J].J Am Coll Cardiol,1996,28(1):74-81.
  • 3Peterson ED,Lansky AJ,Anstrom KJ,et al.Evolving trends in interventional device use and outcomes:results from the national cardiovascular network database[J].Am Heart J,2000,139(2):198-207.
  • 4郭继鸿,许俊堂.冠心病介入治疗围手术期的抗凝治疗[J].中国实用内科杂志,2005,25(1):5-7. 被引量：21
  • 5Kobayashi Y,de Gregorio J,Kobayashi N,et al.Stented segment length as an independent predictor of restenosis[J].J Am Coll Cardiol,1999,34(3):651-659.
  • 6Valgimigli M,Percoco G,Malagutti P,et al.Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction:a randomized trial[J].JAMA,2005,293(17):2109-2117.
  • 7Stone GW,Ellis SG,Cox DA,et al.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350(3):221-231.
  • 8Degertekin M,Serruys PW,Foley DP,et al.Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation:long-term (up to 2 years) clinical,angiographic,and intravascular ultrasound follow-up[J].Circulation,2002,106(13):1610-1613.
  • 9Moussa I,Leon MB,Baim DS,et al.Impact of sirolimus-eluting stents on outcome in diabetic patients:a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy[J].Circulation,2004,109(19):2273-2278.
  • 10朱国英.药物涂层支架的应用[J].心肺血管病杂志,2005,24(1):51-53. 被引量：12

二级参考文献43

  • 1罗助荣,盖晓波.延迟性血运重建术对溶栓失败的急性心肌梗死患者近远期预后的影响[J].心脏杂志,2004,16(6):550-552. 被引量：1
  • 2[1]Rigter H,Meijler AP,McDonnell J,et al.Indications for coronary revascularisation:a Dutch perspective[J].Heart,1997,77:211-218.
  • 3[2]Indolfi C,Pavia M,Angelillo IF.Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)[J] Am J Cardiol,2005,95:1146-1152.
  • 4[3]Nakamura S,Muthusamy TS,Bae JH,et al.Impact of Sirolimus-Eluting Stent on the Outcome of Patients With Chronic Total Occlusions.Am J Cardiol,2005,95:161-166.
  • 5[4]Park SJ,Kim YH,Lee BK,et al.Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis:comparison with bare metal stent implantation[J].J Am Coll Cardiol,2005,45(3):351-356.
  • 6Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting[J ]. Nat Eng J Med, 2001,344: 250-256.
  • 7Waksman R, Cheneau E, Ajani AE, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: Results of the washington radiation for in -stent restenosis trial for long lesions studies [J].Circulation, 2003,107:1750-1756.
  • 8Waksman R, Ajani AE, White RL, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts[J]. Nat Eng J Med, 2002,346:1194-1199.
  • 9Gutensohn K, Beythien C, Bau J, et al. In vitro analyses of diamondlike carbon coated stents: Reduction of metal ion release, platelet activation, and thrombogenicity[J]. Thromb Res,2000,99:577-585.
  • 10De Scheerder I, Szilard M, Yanming H, et al. Evaluation of the biocompatibility of two new diamond-like stent coating (Dylyn) in a porcine coronary stent model [J ]. J Invasive Cardiol, 2000,12:389-394.

共引文献40

同被引文献22

引证文献3

二级引证文献10

心血管病学进展
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部